GB0911215D0 - Gamma globin therapy - Google Patents

Gamma globin therapy

Info

Publication number
GB0911215D0
GB0911215D0 GB0911215A GB0911215A GB0911215D0 GB 0911215 D0 GB0911215 D0 GB 0911215D0 GB 0911215 A GB0911215 A GB 0911215A GB 0911215 A GB0911215 A GB 0911215A GB 0911215 D0 GB0911215 D0 GB 0911215D0
Authority
GB
United Kingdom
Prior art keywords
therapy
gamma globin
globin
gamma
globin therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0911215A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Erasmus University Medical Center
Original Assignee
Erasmus University Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erasmus University Medical Center filed Critical Erasmus University Medical Center
Priority to GB0911215A priority Critical patent/GB0911215D0/en
Publication of GB0911215D0 publication Critical patent/GB0911215D0/en
Priority to PCT/EP2010/003854 priority patent/WO2011000516A2/en
Ceased legal-status Critical Current

Links

GB0911215A 2009-06-29 2009-06-29 Gamma globin therapy Ceased GB0911215D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0911215A GB0911215D0 (en) 2009-06-29 2009-06-29 Gamma globin therapy
PCT/EP2010/003854 WO2011000516A2 (en) 2009-06-29 2010-06-29 Gamma globin therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0911215A GB0911215D0 (en) 2009-06-29 2009-06-29 Gamma globin therapy

Publications (1)

Publication Number Publication Date
GB0911215D0 true GB0911215D0 (en) 2009-08-12

Family

ID=41008427

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0911215A Ceased GB0911215D0 (en) 2009-06-29 2009-06-29 Gamma globin therapy

Country Status (2)

Country Link
GB (1) GB0911215D0 (en)
WO (1) WO2011000516A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12473535B2 (en) 2017-01-05 2025-11-18 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Method for preparing reticulocyte simulating particles and platelet simulating particles, and reference control
CN111638261B (en) * 2020-04-17 2023-04-07 融智生物科技（青岛）有限公司 Computing equipment, storage medium and thalassemia screening device and system

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US5175385A (en) 1987-09-03 1992-12-29 Ohio University/Edison Animal Biotechnolgy Center Virus-resistant transgenic mice
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
JP3068180B2 (en) 1990-01-12 2000-07-24 アブジェニックス インコーポレイテッド Generation of heterologous antibodies
RO115498B1 (en) 1993-10-29 2000-03-30 Univ Boston Method for treating neoplasm
US6403647B1 (en) 1996-07-26 2002-06-11 Susan P. Perrine Pulsed administration of compositions for the treatment of blood disorders
GB2344886B (en) 1999-03-10 2000-11-01 Medical Res Council Selection of intracellular immunoglobulins
US8273866B2 (en) 2002-02-20 2012-09-25 Merck Sharp & Dohme Corp. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)
EP1425694A2 (en) 2001-08-03 2004-06-09 Medical Research Council Method of identifying a consensus sequence for intracellular antibodies
GB0226727D0 (en) 2002-11-15 2002-12-24 Medical Res Council Intrabodies
WO2003077945A1 (en) 2002-03-14 2003-09-25 Medical Research Council Intracellular antibodies
ITTO20020684A1 (en) 2002-07-31 2004-02-01 Associazione Veneta Per La Lotta Alla Talassemia NEW USE OF ANGELICINA AND ITS STRUCTURAL ANALOGUES.
GB0226729D0 (en) 2002-11-15 2002-12-24 Medical Res Council Intracellular antibodies
US20070042937A1 (en) 2003-08-01 2007-02-22 Fibrogen, Inc. Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers
US20080008651A1 (en) * 2006-05-25 2008-01-10 The Regents Of The University Of Michigan Screening Methods and Transgenic Animals for the Treatment of Beta-Globin Related Disease and Conditions

Also Published As

Publication number Publication date
WO2011000516A3 (en) 2011-04-14
WO2011000516A2 (en) 2011-01-06

Similar Documents

Publication Publication Date Title
IL222481A0 (en) Combination therapy
EP2552323A4 (en) Combination therapy
ZA201303499B (en) Specific diarylhydantoin and diarylthiohydantion compounds
EP2417591A4 (en) Reducing medical error
PT2389212T (en) Syringe
IL206654A0 (en) Combination therapy
EP2543336A4 (en) Articulator
IL215481A0 (en) Improved glucocorticoid therapy
GB201015822D0 (en) Medical ruggedised case
EP2515645A4 (en) Antifungal therapy
GB201005394D0 (en) Therapy
GB0908425D0 (en) Medical use
GB0916997D0 (en) Combination therapy
GB0911215D0 (en) Gamma globin therapy
GB0803948D0 (en) Combination therapy
GB0907973D0 (en) Combination therapy
GB0906026D0 (en) Therapeutic compounds
GB0922316D0 (en) Syringe
GB0903319D0 (en) Therapy
GB0903321D0 (en) Therapy
GB0914820D0 (en) WATerian therapy
GB0921244D0 (en) Therapy
GB0922098D0 (en) Therapeutic use
GB0813292D0 (en) Therapy
GB0812659D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)